EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis

Grayson Wass, Kari Clifford, Rathan M Subramaniam

Journal of Nuclear Medicine · 2023-08 · 64 (8) · 1218-1224

DOI: 10.2967/jnumed.123.265471 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 08.06.2023. Verfasst von Grayson Wass und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Quinolines. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibroblast-activation protein is a promising target for oncologic molecular imaging. Studies show that fibroblast activation protein inhibitor (FAPI) radiotracers are accurate diagnostics with favorable tumor-to-background ratios across various cancers. Therefore, we performed a systematic review and metaanalysis to assess the diagnostic performance of FAPI PET/CT in comparison with [18F]FDG PET/CT, the most widely used radiotracer in oncology.

Methods

We conducted a systematic search in MEDLINE, Embase, Scopus, PubMed, Cochrane Central Register of Controlled Trials, relevant trial registries, and bibliographies. The search consisted of combinations of terms for 3 topics: neoplasia, PET/CT, and FAPI. Two authors independently screened retrieved articles using predefined inclusion and exclusion criteria and extracted the data. Study quality was assessed using the criteria of QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies 2). For each study, the sensitivity, specificity, and 95% CIs were calculated to determine diagnostic accuracy for primary, nodal, and metastatic lesions. A random-effects metaanalysis was used for pooling the data, and heterogeneity was assessed (I2 index).

Results

Thirty-nine studies (1,259 patients) investigating the use of FAPI PET/CT were included. On a patient-based analysis, pooled sensitivity was 0.99 (95% CI, 0.97-1.0) for the detection of primary lesions. Pooled sensitivity for nodal and distant metastases was 0.91 (95% CI, 0.81-0.96) and 0.99 (95% CI, 0.96-1.0), respectively. On a paired analysis between FAPI and [18F]FDG PET/CT, FAPI had a higher sensitivity in the detection of primary, nodal, and metastatic lesions (all P < 0.001). The differences in sensitivities between FAPI and [18F]FDG were statistically significant. In terms of heterogeneity, analyses on primary lesions were moderately affected, distant metastatic lesions were highly affected, and the nodal metastatic analyses had negligible heterogeneity.

Conclusion

The diagnostic performance of FAPI PET/CT is superior to that of [18F]FDG in the detection of primary, nodal, and distant metastases. However, further studies are needed to better evaluate its utility and indication in specific cancer types and clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyQuinolinesHumansFluorodeoxyglucose F18Medical OncologyPositron-Emission TomographyMolecular ImagingGallium Radioisotopes

Stichwörter der Autor:innen

FAPIPET/CTmetaanalysisneoplasiaradiology

Substanzen

Fluorodeoxyglucose F18Gallium RadioisotopesQuinolines

Autor:innen und Institutionen

  • Department of Medicine, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand.
  • Surgical Outcomes Research Centre, Department of Surgical Sciences, University of Otago Medical School, Dunedin, New Zealand.
  • Department of Medicine, Dunedin School of Medicine, University of Otago Medical School, Dunedin, New Zealand; rathan.subramaniam@otago.ac.nz.
  • Department of Radiology, Duke University, Durham, North Carolina; and.
  • Faculty of Medicine, Nursing, Midwifery, and Health Sciences, University of Notre Dame Australia, Sydney, Australia.

Zitieren

APA

Wass, G., Clifford, K., & Subramaniam, R. M. (2023). Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis. Journal of Nuclear Medicine, 64(8), 1218-1224. https://doi.org/10.2967/jnumed.123.265471

Vancouver

Wass G, Clifford K, Subramaniam RM. Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis. Journal of Nuclear Medicine. 2023;64(8):1218-1224. doi:10.2967/jnumed.123.265471

BibTeX
@article{Wass2023,
  author = {Wass, Grayson and Clifford, Kari and Subramaniam, Rathan M},
  title = {Evaluation of the Diagnostic Accuracy of FAPI PET/CT in Oncologic Studies: Systematic Review and Metaanalysis},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  volume = {64},
  number = {8},
  pages = {1218--1224},
  doi = {10.2967/jnumed.123.265471}
}
Kostenlos starten →